CureMatch Articles & News
Exciting results obtained by our decision-support platform - we presented our research at #AACR2018 and showed other cancer researchers our discovery of how CureMatch is revolutionizing Cancer treatment today. This study highlights the possible benefits of an evidence-based selection of personalized therapy options in terms of patient response, and validates the data mining methods and optimized algorithms used by the CureMatch PreciGENE® therapeutic decision-support system.
New study published in ANTICANCER RESEARCH Journal offers potential proof-of-concept for precision medicine approach to cancer treatment. SAN DIEGO, CA – April 12, 2018: A new in vitro cancer study supports the concept of matched combination therapies as more effective treatment when compared to matched monotherapies or the current standard of care. Among the most […]
New study in The Oncologist supports the use of blood-based tumor DNA (liquid biopsies) in hepatocellular carcinoma (HCC) to facilitate personalized medicine. The CureMatch decision support platform matches personalized drug combinations for liver cancer patients. SAN DIEGO, CA – March 26, 2018: A new cancer study[1] reports that next-generation sequencing of circulating tumor DNA (ctDNA) can provide therapeutically […]
CureMatch is honored to be selected to present at the 2018 Biocom Life Science Partnering Conference. The Conference is an exclusive global partnering and networking forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. CureMatch has developed a proprietary software platform aimed at guiding oncologists […]
CureMatch is proud to be one of the sponsors of this year’s 14th Moores Cancer Center Industry/Academia Translational Oncology Symposium which will be held on Thursday, February 22, 2018 (8am-6pm) at the Moores Cancer Center, located at 3855 Health Sciences Drive, La Jolla, CA 92093. Featuring Duane Roth Award Lecture Engineered T-Cells: The Sky’s the Limit Carl June, MD […]